🚀 Apply for £10k+ grants with our Startup Launch Kit
shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award

    HT942524PRCRPCSCCA

    Jamie Shortall Grant Officer

    Opening date 17 Jun 2024, 12:00AM

    Closing date 15 Oct 2024, 12:00AM

    Funding Opportunity Number: HT942524PRCRPCSCCA

    Opportunity Category: Discretionary

    Expected Number of Awards: 1

    CFDA Number(s): 12.420 -- Military Medical Research and Development

    Cost Sharing or Matching Requirement: No

    Posted Date: Jun 17, 2024 12:00:00 AM EDT

    Closing Date: Oct 15, 2024 12:00:00 AM EDT

    Estimated Total Program Funding: 32000000

    Award Ceiling: none

    Award Floor: none

    Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

    Agency Name: Jamie Shortall Grant Officer

    Description:

    The FY24 PRCRP CSCCA supports a transdisciplinary collaboration of scientists, clinicians, and consumer advocates, working to illuminate and address urgent and complex issues of importance in cancer research. This mechanism seeks to promote novel approaches to ending cancer through convergent science cancer research. Convergent science as defined by the National Science Foundation (https://www.nsf.gov/od/oia/convergence/index.jsp) “is a means of solving vexing research problems, in particular, complex problems focusing on societal needs. It entails integrating knowledge, methods, and expertise from different disciplines and forming novel frameworks to catalyze scientific discovery and innovation.” Convergent science taps into a variety of disciplines to answer the issues in cancer (i.e., prevention, diagnosis/detection, treatment, quality of life, disparities) including but not limited to biomedical sciences, data science, engineering, psychology, and chemistry. Convergent science breaks down the barriers of cancer research and builds a whole answer with tools from different areas of expertise.

    The CSCCA application must identify one of the FY24 Overarching Challenges as a unifying Focal Point for the consortium, and a minimum of three research projects addressing the Focal Point. Additionally, applicants must clearly define how their application investigates at least three different FY24 PRCRP Topic Areas. For example, brain cancer, neuroblastoma, and pediatric brain tumors are three of the FY24 PRCRP Topic Areas and would be acceptable. Three different types of pediatric brain tumors (i.e., pediatric medulloblastomas, diffuse intrinsic pontine glioma, and pediatric astrocytomas) are not considered three different FY24 PRCRP Topic Areas and would not be acceptable. The proposed Convergent Science consortium should demonstrate the potential to catalyze scientific discovery and innovation, significantly advance cancer research, and have a profound positive impact on the lives of cancer patients or those at risk for cancer including Service Members, their Families, other military beneficiaries, and the American public.

    Consumer advocates should be integrated into and play an active role in the leadership and decision-making for the consortium. An individual advocate can only serve as an advisor and team member at one Research Site. The advocates must be cancer patients or a caretaker of patients from the FY24 PRCRP Topic Areas, be active in a cancer advocacy organization, and possess a high level of familiarity with current issues in cancer research. The advocates’ role should be independent of their employment with a participating institution.

    Grantor Contact Information: CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept